Status:
COMPLETED
Radiofrequency Ablation Using Octopus Electrodes for Small Hepatocellular Carcinoma With No-touch Technique
Lead Sponsor:
Seoul National University Hospital
Collaborating Sponsors:
Starmed
Conditions:
Hepatocellular Carcinoma
Radiofrequency Ablation
Eligibility:
All Genders
20-85 years
Phase:
NA
Brief Summary
The aim of this study is to evaluate clinical outcome of RFA for small single nodular HCC using no touch technique with separable clustered electrode (Octopus) in a prospective multicenter manner Part...
Eligibility Criteria
Inclusion
- Child-Pugh class A liver function
- 1 - 2.5 cm sized Single nodular HCC
- without history of previous HCC treatment or with evidence of no recurrence at least 2 years after previous HCC treatment
Exclusion
- more than 2 HCC
- tumor size larger than 2.5 cm
- Child-Pugh class B or C liver function
- invisible tumor even after real-time fusion US guidance
- accompanied by vascular invasion or distant metastasis
- presence of coagulopathy defined as platelet count \< 50,000/mm3 and/or PT-INR \> 50%
Key Trial Info
Start Date :
November 20 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 21 2020
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT03375281
Start Date
November 20 2017
End Date
August 21 2020
Last Update
March 23 2021
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Asan medical Center
Seoul, South Korea, 05505
2
Samsung medical center
Seoul, South Korea, 06351
3
KonKuk university hospital
Seoul, South Korea
4
Saint Mary Hospital
Seoul, South Korea